港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

中慧生物-B

40.060

-0.820-2.01%

成交量：22.28萬

成交額：899.85萬

市值：157.61億

市盈率：-50.93

高：41.500

開：40.880

低：39.560

收：40.880

52周最高：59.600

52周最低：33.000

股本：3.93億

香港流通股本：2.96億

量比：1.24

換手率：0.08%

股息：- -

股息率：- -

每股收益(LYR):-0.787

淨資產收益率：--

總資產收益率：--

市淨率：427.84

市盈率(LYR):-50.93

市銷率: 44.48

資料載入中...

總覽公司新聞資訊公告

港股異動 | 中慧生物-B(02627.HK)再漲超20% 四價流感病毒亞單位疫苗入選商保創新藥目錄初審名單

異動解讀 | 中慧生物-B盤中大漲5.72%，四價流感疫苗入選國家醫保創新藥品初審名單

中慧生物旗下慧爾康欣作為唯一疫苗入選國家醫保創新藥品初審名單

老虎资讯综合

市值超170億港元，三大邏輯揭示中慧生物-B(02627.HK)的資本熱潮

市值超170億港元，三大邏輯揭示中慧生物-B的資本熱潮

中慧生物-B(02627)旗下慧爾康欣®作為唯一疫苗入選國家醫保創新藥品初審名單

從4000倍瘋搶到單日暴漲158%，中慧生物-B（02627）成全球黑天鵝對沖新硬通貨？

中慧生物-B08月12日主力淨流入969.5萬元散户資金拋售

中慧生物-B尾盤漲幅擴大至30%，上市兩日累漲逾230%

老虎资讯综合

異動解讀 | 中慧生物-B上市次日再度大漲24.88%，兩日累漲超200%

一個醫藥IPO開盤漲150%：中慧生物市值超130億

長春高新、天壇生物等：多藥企藥品進展及業績情況更新

港股異動 | 中慧生物-B(02627.HK)上市次日再漲超20% 昨日飆升近158% 總市值突破150億港元

每日醫刻｜醫療器械概念股震盪走強三鑫醫療、賽諾醫療雙雙漲超10%；復星醫藥DPP-1抑制劑授權出海

異動解讀 | 中慧生物-B上市次日繼續大漲，盤中漲幅超5%

甘肅藥監公告藥品領域典型違法案例；中慧生物上市首日股價暴漲

21世纪经济报道

19萬人抽新股、超額認購逾4000倍！中慧生物上市首日盤中漲近170%，實控人夫婦上台敲鑼

每日经济新闻

港股綜述 | 中慧生物-B首日漲近158%，贛鋒鋰業漲近21%；蘋果概念股全天強勢，鴻騰精密漲逾13%

老虎资讯综合

招銀國際成功保薦中慧元通IPO發行並在香港聯交所主板掛牌上市

132億，江蘇啱啱又誕生一家明星IPO

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02627/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02627","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":40.06,"timestamp":1763452410180,"preClose":40.88,"halted":0,"volume":222800,"delay":0,"floatShares":296361845,"shares":393442600,"eps":-0.7865746491897193,"marketStatus":"未開盤","change":-0.82,"latestTime":"11-18 15:53:30","open":40.88,"high":41.5,"low":39.56,"amount":8998472,"amplitude":0.047456,"askPrice":40.26,"askSize":1200,"bidPrice":39.84,"bidSize":3200,"shortable":0,"etf":0,"ttmEps":-0.6823259128539626,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1763515800000},"marketStatusCode":0,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":40.88,"openAndCloseTimeList":[[1763429400000,1763438400000],[1763442000000,1763452800000]],"volumeRatio":1.239706,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02627\",,,,,undefined,":{"symbol":"02627","floatShares":296361845,"roa":"--","roe":"--","lyrEps":-0.786575,"volumeRatio":1.239706,"shares":393442600,"dividePrice":0,"high":41.5,"amplitude":0.047456,"preClose":40.88,"low":39.56,"week52Low":33,"pbRate":"427.84","psRate":"44.48","week52High":59.6,"institutionHeld":0,"latestPrice":40.06,"committee":0.454545,"eps":-0.7865746491897193,"divideRate":0,"volume":222800,"delay":0,"ttmEps":-0.6823259128539626,"open":40.88,"prevYearClose":12.9,"prevWeekClose":43.2,"prevMonthClose":40.3,"prevQuarterClose":49.3,"fiveDayClose":40.34,"twentyDayClose":45,"sixtyDayClose":49.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02627\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02627","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02627\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02627\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02627\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02627","date":"2025-11-17","current":-58.720062,"percent":0.573529,"low":-83.59026,"twenty":-76.862388,"median":-66.554289,"eighty":-63.630513,"high":-18.07815,"avg":-67.984815,"sd":9.653308,"marketCap":16083933488},"quantilePoints":[{"date":"2025-08-08","current":-18.07815,"twenty":-18.07815,"median":-18.07815,"eighty":-18.07815,"marketCap":5586884920},{"date":"2025-08-15","current":-60.155426,"twenty":-60.155426,"median":-56.438909,"eighty":-42.414982,"marketCap":18562621868},{"date":"2025-08-22","current":-65.870069,"twenty":-65.897052,"median":-63.746879,"eighty":-55.654938,"marketCap":20262293900},{"date":"2025-08-29","current":-64.920623,"twenty":-66.830053,"median":-65.395346,"eighty":-57.22288,"marketCap":20065572600},{"date":"2025-09-05","current":-62.716917,"twenty":-66.416243,"median":-63.912829,"eighty":-60.155426,"marketCap":19365244772},{"date":"2025-09-12","current":-62.655098,"twenty":-66.251138,"median":-63.08644,"eighty":-59.27469,"marketCap":19380982476},{"date":"2025-09-19","current":-81.048551,"twenty":-68.315951,"median":-63.912829,"eighty":-59.882299,"marketCap":19888523430},{"date":"2025-09-26","current":-77.095946,"twenty":-77.153546,"median":-65.395346,"eighty":-60.155426,"marketCap":18869507096},{"date":"2025-10-03","current":-76.784092,"twenty":-77.86406,"median":-66.074095,"eighty":-61.128611,"marketCap":18838031688},{"date":"2025-10-10","current":-75.450727,"twenty":-78.338288,"median":-66.623148,"eighty":-61.710077,"marketCap":18483933348},{"date":"2025-10-17","current":-70.044793,"twenty":-77.841467,"median":-68.315951,"eighty":-62.332762,"marketCap":17146228508},{"date":"2025-10-24","current":-70.694139,"twenty":-77.356453,"median":-69.86748,"eighty":-62.632094,"marketCap":17311474400},{"date":"2025-10-31","current":-64.652972,"twenty":-77.130506,"median":-68.586563,"eighty":-62.679826,"marketCap":15855736780},{"date":"2025-11-07","current":-65.014442,"twenty":-77.0495,"median":-67.012733,"eighty":-63.012535,"marketCap":15934425300},{"date":"2025-11-14","current":-69.152784,"twenty":-76.901535,"median":-66.692171,"eighty":-63.572329,"marketCap":16996720320},{"date":"2025-11-17","current":-65.526738,"twenty":-76.862388,"median":-66.554289,"eighty":-63.630513,"marketCap":16083933488}],"updateTime":1763458634322},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02627\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559673494","title":"港股異動 | 中慧生物-B(02627.HK)再漲超20% 四價流感病毒亞單位疫苗入選商保創新藥目錄初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2559673494","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559673494?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:43","pubTimestamp":1755049381,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","159646","BK1161","159992","06978","02627"],"gpt_icon":0},{"id":"1119727961","title":"異動解讀 | 中慧生物-B盤中大漲5.72%，四價流感疫苗入選國家醫保創新藥品初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1119727961","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119727961?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:33","pubTimestamp":1755048780,"startTime":"0","endTime":"0","summary":"中慧生物-B今日盘中大涨5.72%，引发市场关注。消息面上，公司旗下四价流感病毒亚单位疫苗获纳入2025年度国家商业健康保险创新药品目录通过初步审查的名单，成为当中唯一一款疫苗产品。分析人士认为，慧尔康欣作为唯一疫苗产品入选国家医保创新药品初审名单，有望进一步提升其市场竞争力和销售前景。此外，这一消息也反映了中慧生物-B在创新疫苗研发和商业化方面的实力，有助于增强投资者信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02627"],"gpt_icon":1},{"id":"1163046330","title":"中慧生物旗下慧爾康欣作為唯一疫苗入選國家醫保創新藥品初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1163046330","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163046330?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 09:31","pubTimestamp":1755048719,"startTime":"0","endTime":"0","summary":"8月13日，$中慧生物-B(02627)$盘初再飙逾15%，总市值超200亿港元！旗下慧尔康欣作为唯一疫苗入选国家医保创新药品初审名单。","market":"hk","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"feece2e65780deb9a483e9ba56c7acc5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"中慧生物旗下慧尔康欣作为唯一疫苗入选国家医保创新药品初审名单","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"2559678586","title":"市值超170億港元，三大邏輯揭示中慧生物-B(02627.HK)的資本熱潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2559678586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559678586?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 08:36","pubTimestamp":1755045414,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["YANG","HEXmain","HSCEI","07226","02627","HSTECH","BK4614"],"gpt_icon":0},{"id":"2559678580","title":"市值超170億港元，三大邏輯揭示中慧生物-B的資本熱潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2559678580","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559678580?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 08:36","pubTimestamp":1755045414,"startTime":"0","endTime":"0","summary":"当8月11日$港交所$的铜锣敲响，$中慧生物-B$瞬间点燃资本市场的热情。中慧生物股此次上市的火爆早有预兆。公开发售阶段19.1万人疯抢，超额认购倍数达4007倍，冻结资金超过2100亿港元，成为年内18A生物科技板块无可争议的“超购王”。值得一提的是，在中慧生物的募资计划中预留了战略性并购冗余度，超10%资金可用于横向整合。","market":"hk","thumbnail":"https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5ce7e4c84e3c54b81fbaee9cb1c77ad9"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328846.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":1},{"id":"2559620416","title":"中慧生物-B(02627)旗下慧爾康欣®作為唯一疫苗入選國家醫保創新藥品初審名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2559620416","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559620416?lang=zh_tw&edition=fundamental","pubTime":"2025-08-13 08:20","pubTimestamp":1755044428,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，根据国家医疗保障局于2025年8月12日发布的公告，本年度国家商业健康保险创新药品目录通过初步审查的名单中，包括唯一一款疫苗产品—四价流感病毒亚单位疫苗。该产品在传统病毒裂解疫苗的基础上进行重大升级，具有保护全面、组分抗原纯度高、不良反应风险低等优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"feece2e65780deb9a483e9ba56c7acc5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328838.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","02627"],"gpt_icon":0},{"id":"2559930623","title":"從4000倍瘋搶到單日暴漲158%，中慧生物-B（02627）成全球黑天鵝對沖新硬通貨？","url":"https://stock-news.laohu8.com/highlight/detail?id=2559930623","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559930623?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 23:54","pubTimestamp":1755014086,"startTime":"0","endTime":"0","summary":"当2025年8月11日港交所的铜锣敲响，中慧生物-B瞬间点燃资本市场的热情。这只新股以12.9港元发行价开盘，最高飙升近170%，最终收盘定格于33.28港元，单日暴涨157.98%，一举创下2025年港股新股首日涨幅最高纪录。次日，中慧生物股价继续狂飙，大涨31.31%，市值突破170亿港元。中慧生物股此次上市的火爆早有预兆。除了上述两大逻辑外，中慧生物被全球长线基金们爆买的另一个原因可能是中国创新药疫苗龙头对冲全球黑天鹅事件的对冲策略。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1328801.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627"],"gpt_icon":1},{"id":"2558561043","title":"中慧生物-B08月12日主力淨流入969.5萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2558561043","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558561043?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 16:15","pubTimestamp":1754986534,"startTime":"0","endTime":"0","summary":"08月12日, 中慧生物-B股价涨31.31%，报收43.70元，成交金额1.7亿元，换手率1.43%，振幅31.19%，量比0.00。该股近5个交易日上涨237.21%，主力资金累计净流入969.5万元；近20日主力资金累计净流入969.5万元，其中净流入天数为1日。该股主力净额占比0.07%，港股市场排名99/2670。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165910a483bb27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812165910a483bb27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627"],"gpt_icon":0},{"id":"1165906624","title":"中慧生物-B尾盤漲幅擴大至30%，上市兩日累漲逾230%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165906624","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165906624?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 15:50","pubTimestamp":1754985029,"startTime":"0","endTime":"0","summary":"8月12日，$中慧生物-B(02627)$上市次日续涨近5%，该股昨日上市首日大幅收涨近158%。","market":"hk","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02627"],"gpt_icon":0},{"id":"1198395305","title":"異動解讀 | 中慧生物-B上市次日再度大漲24.88%，兩日累漲超200%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198395305","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198395305?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 15:43","pubTimestamp":1754984583,"startTime":"0","endTime":"0","summary":"8月12日，中慧生物-B延续上市首日的强势表现，盘中大涨24.88%，报41.56港元。截至发稿，该股涨幅收窄至19.35%，报39.72港元。加上昨日157.98%的涨幅，中慧生物-B上市两日累计涨幅已突破200%，总市值超过150亿港元。中慧生物-B于8月11日在港交所主板挂牌上市，发行价为12.9港元/股。公开资料显示，中慧生物致力于疫苗的研发、制造及商业化。尽管中慧生物-B上市后表现亮眼，但投资者仍需关注公司的长期发展。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c87cae35bf9659f431e522bd02af029a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02627"],"gpt_icon":0},{"id":"2558934614","title":"一個醫藥IPO開盤漲150%：中慧生物市值超130億","url":"https://stock-news.laohu8.com/highlight/detail?id=2558934614","media":"投资界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558934614?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 14:27","pubTimestamp":1754980044,"startTime":"0","endTime":"0","summary":"早在2019年4月，中慧生物完成1.3亿元A轮融资，南京高特佳、泰州金泰弘毅基金参投。为应对内卷，中慧生物加大产品推广力度，慧尔康欣在全国30个省份完成市场准入，获超过1100家区县级疾控中心选用。最新一幕出现在上周，北海康成意外成为港股生物医药板块的领头羊，最高涨幅超过30%。7月底，其港股单日市值暴涨超1100亿港元，总市值突破5600亿港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812143008a4836f9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812143008a4836f9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1515","BK1161","BK1574","02627"],"gpt_icon":1},{"id":"2558135446","title":"長春高新、天壇生物等：多藥企藥品進展及業績情況更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2558135446","media":"和讯网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558135446?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 12:12","pubTimestamp":1754971969,"startTime":"0","endTime":"0","summary":"2024年4月首批296种药品获批，2025年8月8日第二批249种药品获批，可在新街坊卫生站供澳门居民使用。目前共有367种、545个品规药品可供使用。8月11日，长春高新公告，子公司金赛药业卡麦角林片临床试验申请获批，国内尚无同品种产品上市，将推动后续开发。8月8日，星昊医药公告，2025半年度营业收入3.08亿元，同比降4.08%；净利润4108万元，同比降32.01%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812122035a4833a7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812122035a4833a7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0075","688029","000661","600161","BK0057","BK0185","02627","MRK","600196","BK0010","02196","BK0168","BK0028","BK0082","BK0188","BK0046","BK0239"],"gpt_icon":0},{"id":"2558528690","title":"港股異動 | 中慧生物-B(02627.HK)上市次日再漲超20% 昨日飆升近158% 總市值突破150億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558528690","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558528690?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 11:03","pubTimestamp":1754967825,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d71e634b2f4acf7c3815ac7007e4a034","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02627"],"gpt_icon":0},{"id":"2558961822","title":"每日醫刻｜醫療器械概念股震盪走強 三鑫醫療、賽諾醫療雙雙漲超10%；復星醫藥DPP-1抑制劑授權出海","url":"https://stock-news.laohu8.com/highlight/detail?id=2558961822","media":"财健道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558961822?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 10:47","pubTimestamp":1754966860,"startTime":"0","endTime":"0","summary":"将“财健道”设为星标持续关注，不错过好看每日医刻1医疗器械概念股震荡走强 三鑫医疗、赛诺医疗双双涨超10%8月12日开盘，三鑫医疗、赛诺医疗双双涨超10%，麦澜德、中红医疗、正海生物、山外山、戴维医疗、南微医学等涨超5%。3复星医药DPP-1抑制剂授权出海8月11日，复星医药宣布其控股子公司复星医药产业与Expedition签订许可协议，授予后者在除中国境内及港澳地区以外地区开发、生产及商业化XH-S004的权利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812113038a483262b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812113038a483262b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688108","BK1583","02196","02627","09997","09996","688331","09995","BK1222","BK1100","BK1191","BK1515","BK1574","600196","BK1593"],"gpt_icon":0},{"id":"1124440401","title":"異動解讀 | 中慧生物-B上市次日繼續大漲，盤中漲幅超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1124440401","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124440401?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 09:35","pubTimestamp":1754962514,"startTime":"0","endTime":"0","summary":"中慧生物-B在上市首日表现强劲后，今日开盘后继续保持上涨势头。截至上午9:33，该股盘中大涨5.05%。昨日，中慧生物-B在港交所主板挂牌上市，首日收盘价报33.28港元，较发行价12.9港元大涨157.98%，市值超130亿港元。市场分析人士指出，中慧生物-B上市后持续走强，反映了投资者对公司前景的看好。同时，考虑到疫苗行业的激烈竞争，中慧生物未来仍需在市场拓展和研发创新等方面持续发力，以巩固其市场地位。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d71e634b2f4acf7c3815ac7007e4a034","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02627"],"gpt_icon":1},{"id":"2558699202","title":"甘肅藥監公告藥品領域典型違法案例；中慧生物上市首日股價暴漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2558699202","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558699202?lang=zh_tw&edition=fundamental","pubTime":"2025-08-12 08:37","pubTimestamp":1754959024,"startTime":"0","endTime":"0","summary":"甘肃省药品监督管理局公布5起药品领域违法案件典型案例8月11日，“甘肃药品监管”官微发文指出，按照国家药监局工作要求，持续加强药品全链条、全生命周期监督管理，严厉打击违法犯罪行为，依法查处了一批药品领域违法案件，切实保障人民群众身体健康和用药安全，同时公布5起药品领域违法案件典型案例。本产品尚无国内和进口产品上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812083949a482cfec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"d71e634b2f4acf7c3815ac7007e4a034","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812083949a482cfec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","BK1515","02627","BK1574"],"gpt_icon":1},{"id":"2558664959","title":"19萬人抽新股、超額認購逾4000倍！中慧生物上市首日盤中漲近170%，實控人夫婦上台敲鑼","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664959","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558664959?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 23:12","pubTimestamp":1754925120,"startTime":"0","endTime":"0","summary":"上市首日，中慧生物以33.0港元/股的价格开盘，盘中涨幅一度逼近170%。超额认购逾4000倍，成为全市场新股第三名在上市前，中慧生物已完成了多方融资，吸引了高特佳医疗、盈科资本、毅达资本等投资机构。配发结果显示，中慧生物全球发售3344.26万股，香港公开发售占11.95%，国际发售占88.05%。据利弗莫尔证券显示，中慧生物暗盘收涨约160%，位居年内新股首位。相关差额已反映于2024年的经营业绩中，占该年度收入的3.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811231448a6dfddfc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811231448a6dfddfc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627"],"gpt_icon":1},{"id":"1160178506","title":"港股綜述 | 中慧生物-B首日漲近158%，贛鋒鋰業漲近21%；蘋果概念股全天強勢，鴻騰精密漲逾13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1160178506","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160178506?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 16:48","pubTimestamp":1754902120,"startTime":"0","endTime":"0","summary":"港股行情港股三大指数收盘涨跌不一，恒生指数涨0.19%，恒生科技指数跌0.01%，$国企指数跌0.08%。个股方面：$中慧生物-B$港股上市首日上涨157.98%。“锂电双雄”齐升， $赣锋锂业$涨近21%， $天齐锂业$涨超18%，$宁德时代$宜春项目采矿许可证8月9日到期后已暂停开采作业。纯电续航450km，将于第四季度正式推出。","market":"us","thumbnail":"https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a5d11890cd6ccd454a56d86737fd3353"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9ec9f86d29238d071c1baa0753508aa7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GB00BDT5M118.USD","IE00B19Z8W00.USD","HSCEI","BK4501","002460","06088","BK4614","02627","07226","HSTECH","SG9999006597.SGD","01772","IE0034235303.USD","IE00B4YYXB79.USD","BK4534","AAPL","YANG","BK1508","BK4512","HK0000320223.HKD","SG9999001069.SGD"],"gpt_icon":0},{"id":"2558666493","title":"招銀國際成功保薦中慧元通IPO發行並在香港聯交所主板掛牌上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666493","media":"招银国际","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558666493?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 10:19","pubTimestamp":1754878799,"startTime":"0","endTime":"0","summary":"交易概述2025年8月11日，江苏中慧元通生物科技股份有限公司成功在香港联合交易所主板挂牌上市。招银国际担任中慧元通在香港IPO的联席保荐人、整体协调人、联席全球协调人、联席账簿管理人及联席牵头经办人。中慧元通此次全球发行33,442,600股H股，发行价格为每股12.90港元，总募集金额约4.31亿港元。招银国际融资已逐步成为香港资本市场最为活跃且增长力强劲的金融机构之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811104512a6deb058&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811104512a6deb058&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627"],"gpt_icon":1},{"id":"2558664600","title":"132億，江蘇啱啱又誕生一家明星IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2558664600","media":"投中网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558664600?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 10:14","pubTimestamp":1754878457,"startTime":"0","endTime":"0","summary":"从江苏泰州起步，一家疫苗公司正式登陆港股。江苏泰州，诞生一个明星IPO从搞建筑到卖疫苗，安有才的跨界创业可谓相当成功。如今，他们不仅成长为江苏泰州的明星公司，同时还成功赴港敲响了上市的钟声。同年11月，中慧生物从江苏省药品监督管理局取得药品生产许可证。五个月后，他们又完成用于三岁及以上人群的四价流感病毒亚单位疫苗III期临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811101439973fece7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811101439973fece7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627"],"gpt_icon":1}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":123,"code":"91000000","status":"200"}]}}